However, only vvDD-IL-23 treatment significantly elevated IL-10 mRNA levels in the tumor at day 9 (Figure 3C), suggesting that IL-10 might mediate the vvDD-IL-23 induced viral persistence in tumor. This evidence concerns the gene IL37 and neoplasm.